Israel - Ibrani - Ministry of Health

inovamed ltd - bisoprolol fumarate - טבליות מצופות פילם - bisoprolol fumarate 10 mg - bisoprolol

Israel - Ibrani - Ministry of Health

inovamed ltd - bisoprolol fumarate - טבליות מצופות פילם - bisoprolol fumarate 2.5 mg - bisoprolol

Israel - Ibrani - Ministry of Health

inovamed ltd - bisoprolol fumarate - טבליות מצופות פילם - bisoprolol fumarate 2.5 mg - bisoprolol

Israel - Ibrani - Ministry of Health

inovamed ltd - bisoprolol fumarate - טבליות מצופות פילם - bisoprolol fumarate 5 mg - bisoprolol

Israel - Ibrani - Ministry of Health

inovamed ltd - bisoprolol fumarate - טבליות מצופות פילם - bisoprolol fumarate 5 mg - bisoprolol

Israel - Ibrani - Ministry of Health

unipharm ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 100 mg - sildenafil

Israel - Ibrani - Ministry of Health

unipharm ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 50 mg - sildenafil

Israel - Ibrani - Ministry of Health

teva israel ltd - papaverine hydrochloride - תמיסה להזרקה - papaverine hydrochloride 40 mg / 2 ml - papaverine - papaverine - antispasmodic in visceral spasm, e.g. gastrointestinal colic, biliary and urinary tract spasms. peripheral vascular disease with vasospastic element. vascular spasm associated with acute myocardial infarcion, angina pectoris, peripheral and pulmonary embolism.

Israel - Ibrani - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 5000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

Israel - Ibrani - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 10000 iu / 0.6 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with chemotherapy. treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative erythropoietin deficiency* and are receiving anti-tumor therapy. * deficiency is defined as an